» Articles » PMID: 35631353

Morphine Accumulates in the Retina Following Chronic Systemic Administration

Overview
Publisher MDPI
Specialty Chemistry
Date 2022 May 28
PMID 35631353
Authors
Affiliations
Soon will be listed here.
Abstract

Opioid transport into the central nervous system is crucial for the analgesic efficacy of opioid drugs. Thus, the pharmacokinetics of opioid analgesics such as morphine have been extensively studied in systemic circulation and the brain. While opioid metabolites are routinely detected in the vitreous fluid of the eye during postmortem toxicological analyses, the pharmacokinetics of morphine within the retina of the eye remains largely unexplored. In this study, we measured morphine in mouse retina following systemic exposure. We showed that morphine deposits and persists in the retina long after levels have dropped in the serum. Moreover, we found that morphine concentrations (ng/mg tissue) in the retina exceeded brain morphine concentrations at all time points tested. Perhaps most intriguingly, these data indicate that following chronic systemic exposure, morphine accumulates in the retina, but not in the brain or serum. These results suggest that morphine can accumulate in the retina following chronic use, which could contribute to the deleterious effects of chronic opioid use on both image-forming and non-image-forming visual functions.

Citing Articles

Impact of Δ-Tetrahydrocannabinol and oxycodone co-administration on measures of antinociception, dependence, circadian activity, and reward in mice.

Slivicki R, Wang J, Nhat V, Kravitz A, Creed M, Gereau 4th R bioRxiv. 2023; .

PMID: 38105953 PMC: 10723318. DOI: 10.1101/2023.12.04.569809.


Morphine pharmacokinetics and opioid transporter expression at the blood-retina barrier of male and female mice.

Berezin C, Bergum N, Torres Lopez G, Vigh J Front Pharmacol. 2023; 14:1206104.

PMID: 37388441 PMC: 10301758. DOI: 10.3389/fphar.2023.1206104.


µ-Opioid Receptors Expressed by Intrinsically Photosensitive Retinal Ganglion Cells Contribute to Morphine-Induced Behavioral Sensitization.

Bergum N, Berezin C, King C, Vigh J Int J Mol Sci. 2022; 23(24).

PMID: 36555511 PMC: 9781919. DOI: 10.3390/ijms232415870.


A retinal contribution to opioid-induced sleep disorders?.

Bergum N, Berezin C, Vigh J Front Neurosci. 2022; 16:981939.

PMID: 35992901 PMC: 9388851. DOI: 10.3389/fnins.2022.981939.

References
1.
Boix F, Andersen J, Morland J . Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice. Addict Biol. 2011; 18(1):1-7. DOI: 10.1111/j.1369-1600.2010.00298.x. View

2.
Williams J, Ingram S, Henderson G, Chavkin C, Von Zastrow M, Schulz S . Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev. 2013; 65(1):223-54. PMC: 3565916. DOI: 10.1124/pr.112.005942. View

3.
Pacifici R, Di Carlo S, Bacosi A, Pichini S, Zuccaro P . Pharmacokinetics and cytokine production in heroin and morphine-treated mice. Int J Immunopharmacol. 2000; 22(8):603-14. DOI: 10.1016/s0192-0561(00)00023-0. View

4.
Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J . qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007; 8(2):R19. PMC: 1852402. DOI: 10.1186/gb-2007-8-2-r19. View

5.
Wyman J, Bultman S . Postmortem distribution of heroin metabolites in femoral blood, liver, cerebrospinal fluid, and vitreous humor. J Anal Toxicol. 2004; 28(4):260-3. DOI: 10.1093/jat/28.4.260. View